Dr. Michael Auerbach and Dr. Matti S. Aapro discuss the use of intravenous iron when administering an erythropoiesis-stimulating agent (ESA) to cancer patients. Jane MacNeil of Elsevier Global Medical News (EGMN) reports from the European Society for Medical Oncology Congress in Stockholm.
All Comments